Endosane Pharmaceuticals agrees to Licence Agreement with PreveCeutical Medical thereby Securing Exclusive Rights to Innovative Technology
Berlin/Vancouver, January 16, 2023 – Endosane Pharmaceuticals, a Berlin-based pharmaceutical company, and PreveCeutical Medical Inc. (CSE: PREV, OTCQB: PRVCF, FSE: 18H) of Canada have entered into a licensing agreement through which Endosane Pharmaceuticals has obtained exclusive access and use rights to the Sol-Gel technology developed by PreveCeutical Medical for the delivery of cannabinoid products.